Menaderm Simplex (Beclometasone Dipropionate)

Beclometasone dipropionate binds to glucocorticoid receptors in skin cells, altering gene transcription. This suppresses the production of inflammatory cytokines, reduces leukocyte migration, and limits epidermal cell proliferation, resulting in decreased inflammation and symptom relief.

The specific dose and frequency of Menaderm Simplex are determined by the prescribing clinician based on the severity of the condition, the area of skin involved and patient factors. Patients should follow the prescriber’s instructions precisely.

The safety of beclometasone dipropionate in pregnancy and lactation has not been definitively established. Healthcare providers weigh potential benefits against risks before prescribing, and patients should discuss any concerns with their physician.

To request Menaderm Simplex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and required import documentation.

Menaderm Simplex contains beclometasone dipropionate, a medium‑potency corticosteroid. Compared with lower‑potency agents (e.g., hydrocortisone) it offers stronger anti‑inflammatory effects, while higher‑potency steroids (e.g., clobetasol) may carry greater risk of skin atrophy. Choice depends on disease severity and treatment duration.

Menaderm Simplex should be stored at room temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

The cream or ointment is applied thinly to the affected skin area, usually once or twice daily as directed by a healthcare professional. Hands should be washed before and after application, and the treated area should be gently massaged until the product is absorbed.

Serious risks include skin atrophy, telangiectasia, hypersensitivity reactions and secondary infections. Systemic absorption can lead to adrenal suppression, especially with extensive or prolonged use. Patients should report any unusual skin changes or systemic symptoms to their clinician promptly.

Menaderm Simplex is contraindicated in individuals with known hypersensitivity to beclometasone dipropionate or any formulation excipients. It should also be avoided on untreated bacterial, viral or fungal skin infections, and in patients where systemic corticosteroid exposure is undesirable without medical supervision.